Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Lansen Pharmaceutical Holdings Co, Ltd. (503 HK)
Watchlist
24
Analysis
Health Care
•
China
Lansen Pharmaceutical holdings Ltd. is a pharmaceutical holding company. The Company's subsidiaries produce and sell rheumatic specialty prescription western pharmaceuticals in the Peoples Republic of China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
JMDC
•
01 Oct 2023 07:10
(Mostly) Asia M&A, Sept 2023: JMDC, Pact, Takisawa, Golden Eagle Energy, Dic Corp
For the month of September, 8 new deals were discussed on Smartkarma with an overall deal size of ~US$2bn. The average premium for the new deals...
David Blennerhassett
Follow
852 Views
Share
bearish
•
Lansen Pharmaceutical Holdings Co, Ltd.
•
01 Sep 2021 17:38
Lansen Pharm (503 HK): Here Is Your Exit
A special dividend is a pretty good outcome. On a 24x ex-dividend basis - and with the "event" not announced - I'm disinclined to hold shares here.
David Blennerhassett
Follow
272 Views
Share
bullish
•
Lansen Pharmaceutical Holdings Co, Ltd.
•
08 Jun 2021 19:35
Lansen Pharma (503 HK): This Is Still A Buy
The privatisation of its parent implied a value of $4.28/share for Lansen. I think this still has more to run from here.
David Blennerhassett
Follow
350 Views
Share
bullish
•
Lansen Pharmaceutical Holdings Co, Ltd.
•
14 May 2021 11:20
Lansen Pharma (503 HK): This Is A Buy
Net cash accounts for 84.6% of market cap. The offer for its parent implied a value of $3.82/share. The core underlying business of Lansen was...
David Blennerhassett
Follow
581 Views
Share
First
Previous
2
3
4
5
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x